Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2017-04-18

Clinical Trial Update: Baseline Sexual Function, Cognitive Function, Body Composition and Muscle Parameters and Pharmacokinetics of Transdermal Testosterone Gel in Women With Hypopituitarism

View source ↗

Summary

A clinical trial evaluating transdermal testosterone gel in women with panhypopituitarism has been withdrawn. The study aimed to assess sexual function, cogniti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Transdermal testosterone gel (testosterone)

Snippet

Sponsor: Charles Drew University of Medicine and Science | Conditions: Panhypopituitarism | Status: WITHDRAWN